blog

Maintaining Clinical Trial Momentum during COVID-19 and Beyond

By Elizabeth Gargill on Thu, Apr 23, 2020 | 1 min read

In our latest Pharma15 Live! COVID-19 special report, BBK's President Matt Kibby introduces a new framework for helping clinical trial sponsors maintain study momentum during COVID-19 and beyond.

The framework features strategies for minimizing disruption during four key stages of the study lifecycle.

Topics: Patient Engagement, Patient Enrollment, COVID-19, Coronavirus, Matt Kibby

 
Subscribe To Our Blog